Hikal LtdPharmaceuticalsINE475B01022Consolidated₹226.04+0.75 (+0.33%)Jun-26
Valuation
Market Cap₹2.79K Cr
TTM PE-82.50x
Forward PE1883.67x
PEG2.68
Book Value₹97.23
P/B2.32x
TTM EPS₹-2.74
Fwd EPS₹0.12
TTM Revenue₹1.74K Cr
TTM PAT₹-33.80 Cr
TTM EBITDA₹232.30 Cr
TTM EBIT₹65.20 Cr
Last Qtr PAT₹-7.40 Cr
Last Qtr EBITDA₹37.00 Cr
Last Qtr EBIT₹-5.70 Cr
Profitability
ROE-2.82%
ROCE3.10%
TTM NPM-1.95%
TTM EBITDA %13.39%
Curr OPM-1.83%
Last OPM2.74%
Curr NPM—
Last NPM—
Curr EPS₹-0.60
Last EPS₹1.17
Balance sheet
Equity₹24.70 Cr
Reserve₹1.17K Cr
Total Debt₹684.10 Cr
D/E0.57x
Interest %-201.35%
Curr Interest₹14.90 Cr
Price / range
Close₹226.04
vs 52W High—
vs 52W Low—
MA50—
MA200—
Returns
1D+0.33%
1W+0.48%
1M+4.08%
3M+13.82%
6M+30.13%
1Y-15.39%
2Y-40.62%
3Y-26.98%
5Y-66.54%
Diwali-0.42%
Sector peers — Pharmaceuticals
Financial Results
Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS
Standalone
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Consolidated
16 lines · 6 periodsYearly results
Last 6 financial years · YoY % vs previous FY
Corporate Actions
Dividends, bonus issues, and stock splits